Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Sonia Pagliusi"'
Autor:
Sonia Pagliusi, Yvette Madrid, Yudha Bramanti, Taufik Wilmansyah, Huilin Yu, Analia Acebal, Komarapuram R. Krishnamurthy, Venkatapathi Raju Pinnamaraju, Padmakar Jadhav, Rachel Park, Lingjiang Yang
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100366- (2023)
The use of global standards, and the placement of barcodes and data matrix codes on vaccine labels and other levels of packaging are crucial elements for the traceability of finished vaccine products. Vaccine manufacturers are committed to improving
Externí odkaz:
https://doaj.org/article/8d9d26a6f5bb41b495063de3c21c57ed
Publikováno v:
Vaccine: X, Vol 13, Iss , Pp 100255- (2023)
Vaccine development, in most cases, is a long, complex process, often lasting years and involving a combination of public and private stakeholders. Particularly, the vaccine clinical development process is highly regulated by several guidelines, regu
Externí odkaz:
https://doaj.org/article/594438c230a048179586c50c97a4974d
Autor:
Stephen Jarrett, Sonia Pagliusi, Rachel Park, Taufik Wilmansyah, Suresh Jadhav, Patricia Correa Santana, K.R. Krishnamurthy, Lingjiang Yang
Publikováno v:
Vaccine: X, Vol 9, Iss , Pp 100119- (2021)
While stockpiling vaccines adds another layer of complexity to vaccine manufacturing, it constitutes a crucial component of comprehensive disease preparedness and control strategies in public health management. Stockpiling provides the ability to imm
Externí odkaz:
https://doaj.org/article/6ad8651618a64c41bd9fdcb6c334187c
Autor:
Nora Dellepiane, Sonia Pagliusi, Prashant Akut, Sebastian Comellas, Norbert De Clercq, Shubhangi Ghadge, Thierry Gastineau, Mic McGoldrick, Ida Nurnaeni, Lorenz Scheppler
Publikováno v:
Vaccine: X, Vol 6, Iss , Pp 100075- (2020)
A comparison of the regulations and guidelines from 33 countries, across different regions, on the requirements and procedures for the management of chemical, manufacturing and control (CMC) changes for vaccines, also known as post- approval changes
Externí odkaz:
https://doaj.org/article/46b229cc8edd444ca6e8e075bdd48a84
Autor:
Benoit Hayman, Sonia Pagliusi
Publikováno v:
Vaccine: X, Vol 5, Iss , Pp 100066- (2020)
The Developing Countries Vaccine Manufacturers Network (DCVMN) is a public health-driven alliance consisting of 43 vaccine manufacturers from 14 countries and territories, operating under the mandate to protect all people against known and emerging i
Externí odkaz:
https://doaj.org/article/7b4af764189d4bf89c706c8f41250195
Publikováno v:
Vaccine: X, Vol 5, Iss , Pp 100068- (2020)
Manufacturers have a significant stake in the vaccine supply chain as their reputations rest on the effectiveness of their vaccines at the point of vaccination. The risks of low performing supply chains are detrimental for the safety and effectivenes
Externí odkaz:
https://doaj.org/article/25b53ad7d7c24b388b5444747ee5d524
Autor:
Sonia Pagliusi, Stephen W. Jarrett, Rachel Park, Yudha Bramanti, Ravi Menon, Courtney Jarrahian, Collrane Frivold, Lingjiang Yang
Publikováno v:
Journal of Advanced Manufacturing and Processing. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::705ae32ce12cfaaf80e02c90572d0046
https://doi.org/10.1002/amp2.10152
https://doi.org/10.1002/amp2.10152
Autor:
Lyudmila Nepomnyashchiy, Alex Bowles, Elizabeth Eyermann, Benoit Hayman, Beth Evans, Sonia Pagliusi
Publikováno v:
Vaccine
Vaccine, 39(8):1190-1194
Vaccine, 39(8):1190-1194
Highlights • 95% of respondents manufacturers have a strategy to pursue innovation. • Innovation targeted at low- and middle- income countries. • Partnerships with biotechs and universities key in driving innovation. • Access to partnerships,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a22fcd3ae38074515848b35b586146f
https://doi.org/10.1016/j.vaccine.2020.12.085
https://doi.org/10.1016/j.vaccine.2020.12.085
Publikováno v:
Vaccine, 38(36):5851-5860
Vaccine
Vaccine
The Developing Countries' Vaccine Manufacturers Network, joined by global health organizations, held its 20th meeting celebrating two decades of vaccine innovations for global public good. Health leaders from industry, academia and global health orga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21813fc5e0fe2912d953b1db37c9b9d2
https://doi.org/10.1016/j.vaccine.2020.05.062
https://doi.org/10.1016/j.vaccine.2020.05.062
Autor:
Joseph S. Bresee, Anonh Xeuatvongsa, Fernando Lobos, Beverly Taylor, Pasi Penttinen, Per Etholm, Samir Desai, Josephine P. Golding, Mark A. McKinlay, Lawrence Kerr, John S. Tam, Dominique Richardson, Atika Abelin, Bruce G. Gellin, Joseph R. Scovitch, Alba Maria Ropero Alvarez, Mark Jit, Philippe Boutet, John M Watson, Sophie Mathewson, Marie Mazur, Bruce Ruscio, Samantha Kluglein, Amanda Bolster, Louise Shaxson, Sonia Pagliusi, Niteen Wairagkar, Jennifer E. Seedorff, Hans Christiansen
Publikováno v:
Vaccine. 38:3179-3183
In March 2019, a group of global health leaders with expertise in influenza, vaccinology and pandemic preparedness was convened for a meeting titled "Shaping Meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::141cc43eee6505304f987f5b78b1bd62
https://doi.org/10.1016/j.vaccine.2020.02.038
https://doi.org/10.1016/j.vaccine.2020.02.038